Marshall Wace North America’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-325,040
| Closed | -$8.48M | – | 1344 |
|
|
2021
Q2 | $8.48M | Buy |
+325,040
| New | +$8.48M | 0.04% | 406 |
|
|
2020
Q4 | – | Sell |
-13,878
| Closed | -$523K | – | 1281 |
|
|
2020
Q3 | $523K | Buy |
+13,878
| New | +$523K | ﹤0.01% | 956 |
|
|
2020
Q2 | – | Sell |
-149,235
| Closed | -$2.9M | – | 1135 |
|
|
2020
Q1 | $2.9M | Sell |
149,235
-43,823
| -23% | -$852K | 0.02% | 417 |
|
|
2019
Q4 | $5.02M | Buy |
+193,058
| New | +$5.02M | 0.02% | 389 |
|
|
2019
Q3 | – | Sell |
-9,531
| Closed | -$256K | – | 1294 |
|
|
2019
Q2 | $256K | Sell |
9,531
-230,529
| -96% | -$6.19M | ﹤0.01% | 1000 |
|
|
2019
Q1 | $6.94M | Buy |
+240,060
| New | +$6.94M | 0.05% | 260 |
|